Article
Innovation or stagnation? EU pharma industry at a crossroads ahead of rules revision
Rating:
0.0
Views:
60
Likes:
1
Library:
1
War, COVID-19 pandemic and vulnerability of supply chains are pushing the EU to be more resilient and self-sufficient in pharmaceutics production. The revision of existing legislation offers the possibility to unlock investments and research in this area.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value